EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Effects of Triiodothyronine (T3) in Ischemic Heart Failure

Phase 1

Recruiting

Conditions: Heart Failure

Interventions: Drug: Thyroid hormone T3
Other: Control Group

First Posted Date: 2022-05-20

Last Posted Date: 2024-08-27

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT05384847

Locations: 🇺🇸
Emory University Hospital Clinical Research Network, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital (EUH), Atlanta, Georgia, United States

Incorporating CV Risk Assessment in AYA Visits

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Behavioral: #HerHeart tool

First Posted Date: 2022-05-20

Last Posted Date: 2023-10-13

Lead Sponsor: Emory University

Target Recruit Count: 60

Registration Number: NCT05384834

Locations: 🇺🇸
Children's Healthcare of Atlanta - Hughes Spalding Research Room, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States

Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial

Phase 2

Recruiting

Conditions: Injection Site Irritation

Interventions: Drug: Lidocaine
Drug: Ondansetron

First Posted Date: 2022-05-18

Last Posted Date: 2024-01-11

Lead Sponsor: Emory University

Target Recruit Count: 120

Registration Number: NCT05378113

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer

Not Applicable

Recruiting

Conditions: Prognostic Stage II Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Chemotherapy-Induced Peripheral Neuropathy
Early Stage Breast Carcinoma
Prognostic Stage I Breast Cancer AJCC v8

Interventions: Other: Transcutaneous Electrical Nerve Stimulation

First Posted Date: 2022-05-10

Last Posted Date: 2024-07-03

Lead Sponsor: Emory University

Target Recruit Count: 27

Registration Number: NCT05368428

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy

Not Applicable

Recruiting

Conditions: Obstructive Sleep Apnea

Interventions: Device: Negative Pressure Ventilator
Device: Pulmonary Function Testing (PFT)
Device: Transcutaneous Phrenic Nerve Stimulation

First Posted Date: 2022-04-28

Last Posted Date: 2024-10-01

Lead Sponsor: Emory University

Target Recruit Count: 200

Registration Number: NCT05350332

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer

Early Phase 1

Recruiting

Conditions: Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm

Interventions: Other: Survey Administration
Other: Text Message-Based Navigation Intervention
Other: Interview

First Posted Date: 2022-04-26

Last Posted Date: 2023-12-18

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT05346692

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases

Phase 1

Recruiting

Conditions: Pathologic Stage IV Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Metastatic Malignant Neoplasm in the Brain
Metastatic Mucosal Melanoma
Metastatic Ocular Melanoma
Melanoma of Unknown Primary
Metastatic Melanoma

Interventions: Biological: Pembrolizumab
Biological: Ipilimumab
Biological: Nivolumab
Procedure: Tumor Treating Fields Therapy
Radiation: Stereotactic Radiosurgery

First Posted Date: 2022-04-22

Last Posted Date: 2024-04-26

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT05341349

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Prevent Maternal Mortality Using Mobile Technology

Not Applicable

Conditions: Post-Partum

Interventions: Behavioral: Prevent Maternal Mortality using Mobile technology (PM3)

First Posted Date: 2022-04-21

Last Posted Date: 2022-04-21

Lead Sponsor: Emory University

Target Recruit Count: 300

Registration Number: NCT05339867

Locations: 🇺🇸
Morehouse School of Medicine, Atlanta, Georgia, United States
🇺🇸
Emory University, Nell Hodgson Woodruff School of Nursing, Atlanta, Georgia, United States

Influenza Human Challenge Model

Phase 1

Recruiting

Conditions: Influenza

Interventions: Biological: Influenza Virus Type A H3N2 Challenge

First Posted Date: 2022-04-18

Last Posted Date: 2024-05-16

Lead Sponsor: Emory University

Target Recruit Count: 40

Registration Number: NCT05332899

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Hope Clinic, Atlanta, Georgia, United States

Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine

Early Phase 1

Recruiting

Conditions: Major Depressive Disorder

Interventions: Other: Placebo
Drug: Ketamine

First Posted Date: 2022-04-14

Last Posted Date: 2024-07-03

Lead Sponsor: Emory University

Target Recruit Count: 140

Registration Number: NCT05327699

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy